Epilepsy and migraine: a diagnostic and therapeutic challenge
Abstract
Migraine and epilepsy are two common, chronic, disabling, paroxysmal neurological disorders. A growing body of evidence from epidemiological, genetic, neurophysiological, and clinical research suggests a complex, bidirectional association between them. Migraine prevalence in epilepsy patients ranges from 8% to 23%, while the reverse is noted at 1%-17%. Both disorders are underpinned by cortical hyperexcitability, dysfunctional neurotransmission, and impaired ion homeostasis. Shared genetic mutations, particularly in genes encoding ion channel subunits such as CACNA1A, SCN1A, and ATP1A2, further support a common channelopathy model. Cortical spreading depression, the electrophysiological substrate of migraine aura, and paroxysmal depolarization shift, a hallmark of epileptic activity, share converging features, including neuronal depolarization, potassium accumulation, glutamate release, and eventual firing suppression. Glial dysfunction, glutamatergic excitotoxicity, and mitochondrial deficits are additional unifying elements. Clinically, the differential diagnosis between migraine with aura and focal seizures remains challenging due to overlapping sensory, visual, and autonomic symptoms. Rare phenomena including ictal epileptic headache, postictal headache, and migraine-triggered seizures further complicate the clinical spectrum. Additionally, certain epilepsy syndromes, such as childhood epilepsy, are strongly associated with migraine. Early recognition of comorbidity is…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.